The 5 stages of biotechnology management.

The biologics pipeline is flush with new technologies, many of which will come with high prices and treat more prevalent conditions. Payers will feel mounting pressure to manage costs effectively. To do this, more sophisticated economic models sensitive to unique and complex mechanisms of action are needed.